Nitric oxide in coronary artery disease: Effects of antioxidants

Nitric oxide in coronary artery disease: Effects of antioxidants

In this review article we examine the main mechanisms leading to decreased nitric oxide (NO) bioavailability, and we present the current strategies available to increase NO levels, mainly by using antioxidants in patients with coronary artery disease. Decreased NO bioavailability in the vasculature...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Tousoulis, D, Antoniades, C, Stefanadis, C
Formato:	Journal article
Idioma:	English
Publicado em:	2006

Registros relacionados

Effects of endothelial nitric oxide synthase gene polymorphisms on oxidative stress, inflammatory status, and coronary atherosclerosis: an example of a transient phenotype.
por: Antoniades, C, et al.
Publicado em: (2007)

Nitric oxide-releasing aspirin: will it say NO to atherothrombosis?
por: Antoniades, C, et al.
Publicado em: (2007)

The oxidative stress menace to coronary vasculature: any place for antioxidants?
por: Briasoulis, A, et al.
Publicado em: (2009)

Statins ameliorate atherosclerosis induced by inhibition of nitric oxide synthase: another novel vascular protective mechanism?
por: Tousoulis, D, et al.
Publicado em: (2008)

Letter regarding article by Becker et al, "Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase".
por: Antoniades, C, et al.
Publicado em: (2005)

Homocysteine: a risk factor for coronary artery disease?
por: Marinou, K, et al.
Publicado em: (2005)

The impact of diabetes mellitus on coronary artery disease: new therapeutic approaches.
por: Tousoulis, D, et al.
Publicado em: (2009)

Endothelial nitric oxide synthase in the vascular wall: Mechanisms regulating its expression and enzymatic function
por: Demosthenous, M, et al.
Publicado em: (2011)

Endothelial nitric oxide synthase in the vascular wall: Mechanisms regulating its expression and enzymatic function
por: Demosthenous, M, et al.
Publicado em: (2011)

Statins and antioxidant vitamins: should co-administration be avoided?
por: Tousoulis, D, et al.
Publicado em: (2006)

Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice.
por: Antoniades, C, et al.
Publicado em: (2003)

Genetic Variability of Methyl-Tetrahydrofolate-Reductase Modifies eNOS Coupling in Human Arteries and Veins: Effects on Vascular Superoxide Generation and Nitric Oxide Bioavailabllity
por: Antoniades, C, et al.
Publicado em: (2008)

Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.
por: Antoniades, C, et al.
Publicado em: (2011)

Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin- mediated endothelial nitric oxide synthase coupling
por: Antoniades, C, et al.
Publicado em: (2011)

Plasma asymmetrical-dimethyl-arginine affects eNOS vascular superoxide radical production and nitric oxide bioavailability in human arteries and veins
por: Antoniades, C, et al.
Publicado em: (2008)

Effects of irbesartan and perindopril on forearm reactive hyperemia and inflammatory process, in normotensive patients with coronary artery disease.
por: Tousoulis, D, et al.
Publicado em: (2008)

Vitamin C affects thrombosis/ fibrinolysis system and reactive hyperemia in patients with type 2 diabetes and coronary artery disease.
por: Tousoulis, D, et al.
Publicado em: (2003)

Endothelial nitric oxide synthase in the vascular wall: Mechanisms regulating its expression and enzymatic function
por: Michael Demosthenous, et al.
Publicado em: (2011-04-01)

Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside.
por: Tousoulis, D, et al.
Publicado em: (2006)

Redox state in arterial grafts predicts left ventricular functional restoration after coronary artery bypass grafting
por: Antoniades, C, et al.
Publicado em: (2009)

Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
por: Tousoulis, D, et al.
Publicado em: (2007)

Assessing inflammatory status in cardiovascular disease.
por: Tousoulis, D, et al.
Publicado em: (2007)

Letter by Antoniades et al regarding article, "Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction".
por: Antoniades, C, et al.
Publicado em: (2010)

Response to Asymmetrical Dimethylarginine, Oxidative Stress, and Atherosclerosis
por: Antoniades, C, et al.
Publicado em: (2011)

Genetic Polymorphism On Methyl-Tetrahydrofolate-Reductase Affects Vascular Superoxide Generation and Nitric Oxide Bioavailability By Regulating eNOS Coupling in Human Arteries and Veins
por: Antoniades, C, et al.
Publicado em: (2009)

Polymorphism of MTHFR gene affects vascular redox and nitric oxide bioavailability by modifying eNOS coupling
por: Antoniades, C, et al.
Publicado em: (2008)

Exercise duration as a determinant of vascular function and antioxidant balance in patients with coronary artery disease.
por: Michaelides, A, et al.
Publicado em: (2011)

Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases.
por: Tousoulis, D, et al.
Publicado em: (2008)

Plasma asymmetrical-dimethyl-arginine (ADMA) regulates nitric oxide bioavailability and vascular superoxide production in human vessels
por: Antoniades, C, et al.
Publicado em: (2007)

Mechanisms regulating myocardial redox state in chronic atrial fibrillation: the role of NADPH-oxidase and uncoupled nitric oxide synthases
por: Margaritis, M, et al.
Publicado em: (2010)

Plasma asymmetrical-dimethyl-arginine (ADMA) as a regulator of vascular redox and nitric oxide bioavailability in human vessels
por: Antoniades, C, et al.
Publicado em: (2007)

Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
por: Antoniades, C, et al.
Publicado em: (2009)

Preoperative evaluation of flow-mediated dilatation in the left radial artery or the right brachial artery, as a predictor of nitric-oxide bioavailability in coronary artery bypass grafts
por: Antoniades, C, et al.
Publicado em: (2006)

Genetic polymorphism on endothelial nitric oxide synthase affects endothelial activation and inflammatory response during the acute phase of myocardial infarction.
por: Antoniades, C, et al.
Publicado em: (2005)

Candidate gene polymorphisms and the 9p21 locus in acute coronary syndromes.
por: Tousoulis, D, et al.
Publicado em: (2008)

Genetic variability of MTHFR affects vascular redox and nitric oxide bioavailability in human vessels, by modifying eNOS coupling
por: Antoniades, C, et al.
Publicado em: (2008)

Pre-operative inflammation and post-operative atrial fibrillation in coronary artery bypass surgery.
por: Paschalis, A, et al.
Publicado em: (2014)

Atorvastatin rapidly modifies vascular redox state and improves nitric oxide bioavailability in human vessels obtained from patients with advanced atherosclerosis
por: Demosthenous, M, et al.
Publicado em: (2010)

Relation of preoperative radial artery flow-mediated dilatation to nitric oxide bioavailability in radial artery grafts used in off-pump coronary artery bypass grafting.
por: Antoniades, C, et al.
Publicado em: (2009)

The impact of statin administration in acute coronary syndromes.
por: Papageorgiou, N, et al.
Publicado em: (2010)